Stay updated on GLPG2737 in Combination With Orkambi Clinical Trial

Sign up to get notified when there's something new on the GLPG2737 in Combination With Orkambi Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLPG2737 in Combination With Orkambi Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:54:43.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a Phase IIa clinical trial evaluating GLPG2737 in Orkambi-treated subjects with cystic fibrosis homozygous for the F508del mutation.
    Difference
    0.2%
    Check dated 2024-06-06T14:32:58.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as age, clinical diagnosis, and health conditions. Previously, this section indicated that no information was provided.
    Difference
    23%
    Check dated 2024-05-22T20:33:28.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:48:32.000Z thumbnail image

Stay in the know with updates to GLPG2737 in Combination With Orkambi Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLPG2737 in Combination With Orkambi Clinical Trial page.